These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 8362248
21. Hemostasis and coagulation monitoring and management during liver transplantation. Dalmau A, Sabaté A, Aparicio I. Curr Opin Organ Transplant; 2009 Jun; 14(3):286-90. PubMed ID: 19300254 [Abstract] [Full Text] [Related]
22. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products. Trzebicki J, Flakiewicz E, Kosieradzki M, Blaszczyk B, Kołacz M, Jureczko L, Pacholczyk M, Chmura A, Lagiewska B, Lisik W, Wasiak D, Kosson D, Kwiatkowski A, Lazowski T. Ann Transplant; 2010 Jun; 15(3):19-24. PubMed ID: 20877262 [Abstract] [Full Text] [Related]
23. Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT). Himmelreich G, Dooijewaard G, Breinl P, Bechstein WO, Neuhaus P, Kluft C, Riess H. Thromb Haemost; 1993 Jan 11; 69(1):56-9. PubMed ID: 8446939 [Abstract] [Full Text] [Related]
24. Hemostasis in children undergoing liver transplantation. Carlier M, Van Obbergh LJ, Veyckemans F, de Kock M, de Beys CC, Lavenne-Pardonge E, Moulin D, Otte JB. Semin Thromb Hemost; 1993 Jan 11; 19(3):218-22. PubMed ID: 8362251 [Abstract] [Full Text] [Related]
25. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect. Molenaar IQ, Legnani C, Groenland TH, Palareti G, Begliomini B, Terpstra OT, Porte RJ. Liver Transpl; 2001 Oct 11; 7(10):896-903. PubMed ID: 11679989 [Abstract] [Full Text] [Related]
26. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass. Wang Y, Liu Y, Han R, Zhu Z, Zhang Y, Wang X, Wang L, Shen Z. Thromb Res; 2008 Oct 11; 122(2):161-6. PubMed ID: 18048090 [Abstract] [Full Text] [Related]
27. Prohemostatic interventions in liver surgery. Stellingwerff M, Brandsma A, Lisman T, Porte RJ. Semin Thromb Hemost; 2012 Apr 11; 38(3):244-9. PubMed ID: 22510858 [Abstract] [Full Text] [Related]
28. Role of leukocytes in hemostasis during orthotopic liver transplantation. Riess H, Jochum M, Machleidt W, Himmelreich G, Bechstein WO, Muser M, Neuhaus P, Roissant R, Huhn D. Semin Thromb Hemost; 1993 Apr 11; 19(3):197-208. PubMed ID: 7689749 [No Abstract] [Full Text] [Related]
29. Transfusion requirements are correlated with the degree of proteolysis of von Willebrand factor during orthotopic liver transplantation. Lattuada A, Mannucci PM, Chen C, Legnani C, Palareti G. Thromb Haemost; 1997 Aug 11; 78(2):813-9. PubMed ID: 9268177 [Abstract] [Full Text] [Related]
32. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin. Segal HC, Hunt BJ, Cottam S, Downing A, Beard C, Francis JL, Potter D, Tan KC. Transplantation; 1994 Dec 27; 58(12):1356-60. PubMed ID: 7528949 [Abstract] [Full Text] [Related]
33. Coagulation profiles and intraoperative substitution requirements during elective piggyback liver transplantation with prophylactic antifibrinolytic therapy. Weber T, Sendt W, Grube T, Scheele J. Transpl Int; 2002 Jun 27; 15(6):310-6. PubMed ID: 12072902 [Abstract] [Full Text] [Related]
36. Does aprotinin really reduce blood loss in orthotopic liver transplantation? Groh J, Welte M, Azad SC, Anthuber M, Haller M, Kratzer MA. Semin Thromb Hemost; 1993 Jun 27; 19(3):306-8. PubMed ID: 7689758 [No Abstract] [Full Text] [Related]